MiNK Therapeutics, Inc. announced that effective December 31, 2021, Dr. Jennifer Buell resigned as Agenus Inc.'s, President and Chief Operating Officer to become the President of company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.89 USD | -1.11% |
|
+1.47% | -16.82% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.82% | 3.5Cr | |
+38.36% | 5.27TCr | |
+38.62% | 3.9TCr | |
-8.63% | 3.85TCr | |
+25.46% | 3.04TCr | |
-11.17% | 2.64TCr | |
+11.44% | 2.61TCr | |
+45.09% | 1.42TCr | |
+32.93% | 1.26TCr | |
-5.30% | 1.15TCr |
- Stock Market
- Equities
- INKT Stock
- News MiNK Therapeutics, Inc.
- Mink Therapeutics, Inc. Announces Appointment of Jennifer Buell as President